2018
DOI: 10.1017/ice.2018.81
|View full text |Cite
|
Sign up to set email alerts
|

Association of an Active Surveillance and Decolonization Program on Incidence of Clinical Cultures Growing Staphylococcus aureus in the Neonatal Intensive Care Unit

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
13
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 10 publications
(23 reference statements)
0
13
0
Order By: Relevance
“…Staphylococcus aureus is a leading cause of invasive bacterial infections in hospitalized infants [1]. Asymptomatic colonization of the anterior nares, the primary anatomic niche for S. aureus , is an important precursor for S. aureus disease [2]. Many neonates become colonized by S. aureus shortly after birth.…”
mentioning
confidence: 99%
“…Staphylococcus aureus is a leading cause of invasive bacterial infections in hospitalized infants [1]. Asymptomatic colonization of the anterior nares, the primary anatomic niche for S. aureus , is an important precursor for S. aureus disease [2]. Many neonates become colonized by S. aureus shortly after birth.…”
mentioning
confidence: 99%
“…Mupirocin applied to the nares combined with the use of chlorhexidine baths (relevant to gestational, >36 0/7 weeks and chronological age, > 4 weeks old) have shown promising reductions in MRSA, 80 , 81 as well as MSSA colonization and infections. 82 Both parents and care providers can contribute to the spread of SA. Recently, Milstone et al, conducted a clinical trial randomizing parents of MRSA colonized neonates to either receive mupirocin and chlorhexidine cloths or placebo.…”
Section: Late Onset Sepsis (Los)mentioning
confidence: 99%
“…Limited data exist on the use of active MSSA surveillance or contact precautions to prevent infections in the NICU. 28,29 Some prospective data show success with routine surveillance of new admissions followed by decolonization with nasal mupirocin to reduce invasive disease. 30 Whether environmental contamination contributes to S. aureus acquisition in the NICU remains unclear.…”
Section: Questionmentioning
confidence: 99%
“…Data showing efficacy and safety of S. aureus decolonization to reduce infection risk are primarily available from observational studies and a recent randomized trial that was not powered to detect a reduction in S. aureus infections. 6,29,30,[35][36][37] Even though decolonization has included treatment with topical antibiotics, topical antiseptics, and rarely, systemic antimicrobials, intranasal mupirocin alone is most commonly used. Intranasal mupirocin is not approved by the US Food and Drug Administration (FDA) for this indication in neonates, yet numerous studies reporting the use of mupirocin for S. aureus decolonization have not identified any clinically relevant adverse effects.…”
Section: Questionmentioning
confidence: 99%